CS
Candriam SCA Portfolio holdings
AUM
$17.3B
This Quarter Return
+29.24%
1 Year Return
+21.68%
3 Year Return
+102.54%
5 Year Return
+176.54%
10 Year Return
+489.52%
AUM
$9.46B
AUM Growth
+$9.46B
(+4.8%)
Cap. Flow
+$53.3M
Cap. Flow
% of AUM
0.56%
Top 10 Holdings %
Top 10 Hldgs %
21.63%
Holding
907
New
103
Increased
256
Reduced
392
Closed
103
Top Buys
| 1 |
BPMC
Blueprint Medicines
BPMC
|
$59.9M |
| 2 |
Merck
MRK
|
$49.9M |
| 3 |
Danaher
DHR
|
$49.5M |
| 4 |
JD.com
JD
|
$44.8M |
| 5 |
Thermo Fisher Scientific
TMO
|
$40.8M |
Top Sells
| 1 |
Regeneron Pharmaceuticals
REGN
|
$114M |
| 2 |
Alibaba
BABA
|
$102M |
| 3 |
Salesforce
CRM
|
$58.9M |
| 4 |
Bristol-Myers Squibb
BMY
|
$58.4M |
| 5 |
Vertex Pharmaceuticals
VRTX
|
$52M |
Sector Composition
| 1 | Healthcare | 34.68% |
| 2 | Technology | 20.98% |
| 3 | Consumer Discretionary | 8.92% |
| 4 | Financials | 8.6% |
| 5 | Communication Services | 7.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
TSMC
TSM
$1.19T
| $63.5M | 0.67% |
1,117,934
-335,203
| -23% | -$19M |
|
|
ALXN
27
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $63.3M | 0.67% |
564,099
-11,695
| -2% | -$1.31M |
|
28
JPMorgan Chase
JPM
$816B
| $60.8M | 0.64% |
646,132
+83,962
| +15% | +$7.9M |
|
29
Cisco
CSCO
$267B
| $57.8M | 0.61% |
1,143,158
-413,605
| -27% | -$20.9M |
|
30
NVIDIA
NVDA
$4.14T
| $57.7M | 0.61% |
147,930
-11,108
| -7% | -$4.33M |
|
31
Johnson & Johnson
JNJ
$426B
| $57.7M | 0.61% |
410,381
+14,735
| +4% | +$2.07M |
|
32
UnitedHealth
UNH
$277B
| $57.6M | 0.61% |
195,341
-26,316
| -12% | -$7.76M |
|
33
Intel
INTC
$104B
| $54.6M | 0.58% |
912,138
-64,060
| -7% | -$3.83M |
|
34
Nike
NKE
$110B
| $54M | 0.57% |
550,299
+136,220
| +33% | +$13.4M |
|
35
PepsiCo
PEP
$202B
| $52.4M | 0.55% |
396,306
-65,028
| -14% | -$8.6M |
|
36
Adobe
ADBE
$147B
| $51.7M | 0.55% |
118,814
-23,596
| -17% | -$10.3M |
|
37
Waste Management
WM
$89.9B
| $50.2M | 0.53% |
474,335
+84,381
| +22% | +$8.94M |
|
38
Broadcom
AVGO
$1.42T
| $50M | 0.53% |
158,321
+6,272
| +4% | +$1.98M |
|
39
Eli Lilly
LLY
$658B
| $47.6M | 0.5% |
290,023
-8,802
| -3% | -$1.45M |
|
40
Bio-Rad Laboratories Class A
BIO
$7.76B
| $46.6M | 0.49% |
103,145
+23,644
| +30% | +$10.7M |
|
41
BioMarin Pharmaceuticals
BMRN
$11.3B
| $45.6M | 0.48% |
369,640
+47,225
| +15% | +$5.82M |
|
|
42
JD.com
JD
$44.3B
| $44.8M | 0.47% |
+744,410
| New | +$44.8M |
|
43
S&P Global
SPGI
$164B
| $44M | 0.46% |
133,670
+30,892
| +30% | +$10.2M |
|
44
Analog Devices
ADI
$119B
| $43.9M | 0.46% |
358,192
+69,550
| +24% | +$8.53M |
|
45
Abbott
ABT
$228B
| $43.5M | 0.46% |
476,059
-180,303
| -27% | -$16.5M |
|
46
Mastercard
MA
$534B
| $42.9M | 0.45% |
145,132
+9,793
| +7% | +$2.9M |
|
47
Rockwell Automation
ROK
$37.7B
| $42M | 0.44% |
197,030
-17,723
| -8% | -$3.78M |
|
|
SPLK
48
DELISTED
Splunk Inc
SPLK
| $41.9M | 0.44% |
210,744
+70,079
| +50% | +$13.9M |
|
|
IMMU
49
DELISTED
Immunomedics Inc
IMMU
| $40M | 0.42% |
1,128,632
+591,558
| +110% | +$21M |
|
50
Apellis Pharmaceuticals
APLS
$3.5B
| $39.5M | 0.42% |
1,210,398
+818,198
| +209% | +$26.7M |
|